Deirdre Hill

Summary

Affiliation: University of New Mexico
Country: USA

Publications

  1. pmc Long-term risk of medical conditions associated with breast cancer treatment
    Deirdre A Hill
    Department of Internal Medicine and Cancer Research and Treatment Center, University of New Mexico, MSC 10 5550, Albuquerque, NM, 87131 0001, USA
    Breast Cancer Res Treat 145:233-43. 2014
  2. pmc Examining the challenges of family recruitment to behavioral intervention trials: factors associated with participation and enrollment in a multi-state colonoscopy intervention trial
    Rebecca G Simmons
    Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, UT 84112, USA
    Trials 14:116. 2013
  3. pmc Method of detection and breast cancer survival disparities in Hispanic women
    Deirdre A Hill
    University of New Mexico Cancer Research and Treatment Center and Department of Internal Medicine, MSC 10 5550, 1 University of New Mexico, Albuquerque, NM 87131 0001, USA
    Cancer Epidemiol Biomarkers Prev 19:2453-60. 2010
  4. ncbi request reprint Strengthening gynecologic cancer prevention studies
    Deirdre A Hill
    Department of Internal Medicine, Division of Epidemiology, University of New Mexico School of Medicine, 1 University of NM, Albuquerque, NM 87131 0001, USA
    Obstet Gynecol Clin North Am 34:639-50, vii. 2007
  5. pmc Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes
    Deirdre A Hill
    Cancer Center and Department of Internal Medicine, UNM School of Medicine, 1 University of New Mexico, MSC 10 5550, Albuquerque, NM 87131 0001, USA
    Blood 108:3161-7. 2006
  6. pmc Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors
    Deirdre A Hill
    Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Blood 106:3358-65. 2005
  7. ncbi request reprint Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    J Natl Cancer Inst 97:1428-37. 2005
  8. ncbi request reprint Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women
    Catherine Schairer
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, EPS, Room 8020 MSC 7234, Rockville, MD 20852 7234, USA
    Cancer Epidemiol Biomarkers Prev 14:1660-5. 2005
  9. ncbi request reprint Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    JAMA 290:465-75. 2003
  10. ncbi request reprint Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women
    Catherine Schairer
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA
    Int J Cancer 108:773-9. 2004

Detail Information

Publications18

  1. pmc Long-term risk of medical conditions associated with breast cancer treatment
    Deirdre A Hill
    Department of Internal Medicine and Cancer Research and Treatment Center, University of New Mexico, MSC 10 5550, Albuquerque, NM, 87131 0001, USA
    Breast Cancer Res Treat 145:233-43. 2014
    ..Responses from survivors a decade following cancer diagnosis demonstrate substantial treatment-related morbidity, and emphasize the need for continued medical surveillance and follow-up care into the second decade post-diagnosis...
  2. pmc Examining the challenges of family recruitment to behavioral intervention trials: factors associated with participation and enrollment in a multi-state colonoscopy intervention trial
    Rebecca G Simmons
    Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, UT 84112, USA
    Trials 14:116. 2013
    ..Furthermore, although use of cancer registries to identify initial cases has increased, to our knowledge no study has examined the relationship between registries and family recruitment outcomes...
  3. pmc Method of detection and breast cancer survival disparities in Hispanic women
    Deirdre A Hill
    University of New Mexico Cancer Research and Treatment Center and Department of Internal Medicine, MSC 10 5550, 1 University of New Mexico, Albuquerque, NM 87131 0001, USA
    Cancer Epidemiol Biomarkers Prev 19:2453-60. 2010
    ..We determined whether survival differences between Hispanic and non-Hispanic women might be attributable to the method of detection, an independent breast cancer prognostic factor in previous studies...
  4. ncbi request reprint Strengthening gynecologic cancer prevention studies
    Deirdre A Hill
    Department of Internal Medicine, Division of Epidemiology, University of New Mexico School of Medicine, 1 University of NM, Albuquerque, NM 87131 0001, USA
    Obstet Gynecol Clin North Am 34:639-50, vii. 2007
    ..Cancer prevention efforts have recently suffered some well-publicized and not-so-well publicized setbacks. The prominence of some of these findings should not overshadow well-established achievements and recent successes...
  5. pmc Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes
    Deirdre A Hill
    Cancer Center and Department of Internal Medicine, UNM School of Medicine, 1 University of New Mexico, MSC 10 5550, Albuquerque, NM 87131 0001, USA
    Blood 108:3161-7. 2006
    ..03) in the nonhomologous end joining (NHEJ)/V(D)J pathway. These NHEJ/V(D)J-related gene variants represent promising candidates for further studies of NHL etiology and require replication in other studies...
  6. pmc Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors
    Deirdre A Hill
    Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Blood 106:3358-65. 2005
    ..The additional increased relative risk of breast cancer after RT for HL is unlikely to be larger among women with a family history of breast or ovarian cancer than among other women...
  7. ncbi request reprint Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    J Natl Cancer Inst 97:1428-37. 2005
    ..We estimated this future risk, taking into account age and calendar year of HL diagnosis, HL treatment information, population breast cancer incidence rates, and competing causes of death...
  8. ncbi request reprint Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women
    Catherine Schairer
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, EPS, Room 8020 MSC 7234, Rockville, MD 20852 7234, USA
    Cancer Epidemiol Biomarkers Prev 14:1660-5. 2005
    ..We sought to determine whether serum concentrations of estrogens, androgens, and sex hormone binding globulin in postmenopausal women were related to the presence of mammary hyperplasia, an established breast cancer risk factor...
  9. ncbi request reprint Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    JAMA 290:465-75. 2003
    ..Quantitative associations between radiotherapy dose delivered to the breast and administered chemotherapy have not been reported to date in large series, nor has the influence of ovarian exposures on subsequent risk...
  10. ncbi request reprint Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women
    Catherine Schairer
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA
    Int J Cancer 108:773-9. 2004
    ..5 (95% CI 0.7-3.0) and 1.6 (95% CI 0.8-3.2), respectively (p trend = 0.35 and 0.25, respectively). Our results suggest that insulin and insulin resistance may play a role in breast pathology in postmenopausal women...
  11. ncbi request reprint Cancer in first-degree relatives and risk of glioma in adults
    Deirdre A Hill
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 7238, USA
    Cancer Epidemiol Biomarkers Prev 12:1443-8. 2003
    ..Shared environmental or genetic factors in families may influence glioma risk. Our findings suggest that individuals with a family history of specific cancers other than glioma may have an increased glioma risk...
  12. ncbi request reprint Pesticide use and breast cancer risk among farmers' wives in the agricultural health study
    Lawrence S Engel
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Am J Epidemiol 161:121-35. 2005
    ..Further follow-up of this cohort should help clarify the relation between pesticide exposure and breast cancer risk...
  13. pmc Etiologic heterogeneity among non-Hodgkin lymphoma subtypes
    Lindsay M Morton
    Division of Cancer Epidemiology and Genetics, National Cancer Institute NCI, National Institutes of Health NIH, Rockville, MD, USA
    Blood 112:5150-60. 2008
    ....
  14. ncbi request reprint Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk
    Michael Hauptmann
    J Natl Cancer Inst 95:1251-2. 2003
  15. ncbi request reprint Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy
    Jessica Chubak
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98195, USA
    Cancer Causes Control 18:1001-7. 2007
    ..It is unknown whether postmenopausal unopposed estrogen users are better off, in terms of endometrial cancer risk, switching to a combined estrogen-progestin regimen or stopping hormone use altogether...
  16. ncbi request reprint Risk factors for the incidence of endometrial cancer according to the aggressiveness of disease
    Jocelyn M Weiss
    Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Am J Epidemiol 164:56-62. 2006
    ..In general, a woman's risk of endometrial cancer appears to be influenced by similar risk factors regardless of disease severity...
  17. ncbi request reprint Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy
    James M Allan
    Epidemiology and Genetics Unit, Department of Biology, University of York, York, United Kingdom, YO10 5YW
    Blood 104:3872-7. 2004
    ..22 for Gln/Gln vs Lys/Lys; 95% CI, 1.04-4.74). These data suggest that the XPD codon 751 glutamine variant protects against myeloid cell death after chemotherapy...
  18. ncbi request reprint Medical radiation, family history of cancer, and benign breast disease in relation to breast cancer risk in young women, USA
    Deirdre A Hill
    Department of Preventive Medicine, University of Southern California, Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles 90033, USA
    Cancer Causes Control 13:711-8. 2002
    ..Some evidence suggests that such risk may be distinctly elevated among women with a family history of breast or ovarian cancer (probably only carriers of specific gene mutations) and women with benign breast disease (BBD)...